While 4 studies in total have explored c-Met expression levels in all various sites of the head and neck, 9 studies have focused only on the oral cavity, 3 only on oropharyngeal tumors and lastly, a single study included solely hypopharyngeal lesions. The gene discussed is MET; the disease is neoplasm of oropharynx.